Overview
SwiftPharma pioneers sustainable, scalable, and affordable plant-made therapeutic proteins including vaccines, antibodies, cytokines, and enzymes. The company uses plants as individual bioreactors to produce high-value, animal-free proteins that redefine safety and sustainability, supporting innovation from proof of concept through production and facility development.
In the news
- SwiftPharma is heading to BioJapan on October 7–9, 2026 at PACIFICO Yokohama! 🇯🇵 We are excited to represent Flanders, Belgium, at BioJapan and connect with the Japanese and international biotechnology community. At SwiftPharma, we are developing a new generation of high-value recombinant proteins produced through plant-based biomanufacturing. Our HyperXpress® transient expression platform uses plants as biofactories to produce complex human recombinant proteins, with a focus on quality, scalability, cost-efficiency and
- A moment we've been looking forward to: construction has officially started on our new facility in Genk! At SwiftPharma, we are working to take animal-derived inputs out of recombinant protein production, using plants as mini-bioreactors to grow next-generation, animal-free proteins. To watch this mission take physical shape, is a moment worth marking. Plant molecular farming isn't exactly familiar territory for a construction partner, so before VILS started designing anything we first showed them the ins and outs of our process.
- We’re proud to have our Founder and CSO, Jeroen Hofenk, representing SwiftPharma as a speaker at the upcoming CESPE event. Jeroen will contribute to the discussion on #PlantMolecularPharming, sharing perspectives on the opportunities and future potential of plant-based platforms in biopharmaceutical production. Thank you to CESPE for creating a forum that brings experts, innovators, and industry leaders together. #SwiftPharma #PlantMolecularPharming #Biopharma #Biotechnology #Innovation
- Welcome to the team, Ilse Maes! 💪 We’re delighted to welcome Ilse Maes to our team, a solution-driven professional with a strong track record of bringing people, expertise, and complex technical challenges together. Ilse brings an impressive combination of analytical expertise, R&D experience, and project management skills. During 25 years at DSM, she managed internal customer project portfolios, translated complex scientific needs into practical solutions, and validated more than 25 analytical testing methods. 👩🔬 😎 She then
- We zijn op zoek naar een nieuwe Lab Technician in Genk, Flemish Region (#hiring). Solliciteer vandaag nog of deel deze bijdrage met uw netwerk.
- We zijn op zoek naar een nieuwe QA Manager in Genk, Flemish Region (#hiring). Solliciteer vandaag nog of deel deze bijdrage met uw netwerk.
- We're hiring! As SwiftPharma continues to grow, we're excited to welcome two new colleagues to our team. 🧪 QA Manager Following our current QA Manager's decision to pursue a new opportunity closer to home, we're looking for an experienced professional to build on the strong quality foundations already established and lead the next phase of our Quality Management System. We sincerely thank her for her dedication and valuable contribution to SwiftPharma, and we wish her every success in her future career. 🔗
- Welcome on Board, Boris Van Hiel! 🌱🔬 We are delighted to welcome Boris to the team! With a PhD in Biology from KU Leuven and an impressive international research journey spanning KU Leuven, the University of Melbourne, and Institut Paoli-Calmettes, Boris brings a wealth of expertise in functional genomics, proteomics, molecular oncology, and biotechnology innovation. 🧬⚙️ Over the years, he has successfully bridged the gap between cutting-edge academic research and industry leadership. As Director of Molecular Biology at
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.